Med-Tech Innovation November 28, 2023

1nhaler, a Scotland-based drug delivery device developer, has raised £2 million to develop its single-use dry powder inhaler (DPI).

Inhalable medicines are already widely used to treat conditions such as asthma, epilepsy, allergies and Parkinson’s but, to date, delivery options have been limited due to user accessibility, cost, performance and impact on the environment. 1nhaler has developed a way of enabling different dry powder drugs to be readily delivered in its device.

Other inhalers are typically made from bulky plastic and are expensive to manufacture and distribute. 1nhaler’s sustainable DPI is cardboard-based with the same dimensions as a credit card. The platform includes a breathable membrane which can be tailored to deliver individual drugs to patients.

Investment will allow...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Investments, Medical Devices, Trends
What tariffs mean for the medical device industry - and who will pay for them?
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns
Labcorp to buy Opko unit’s cancer test assets for up to $225M
Qualcomm CEO: AI Is the New User Interface for Devices
FTC sues to block merger of device coatings companies

Share This Article